Santoro, Angela
 Distribuzione geografica
Continente #
NA - Nord America 3.234
AS - Asia 3.138
EU - Europa 1.951
SA - Sud America 725
AF - Africa 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.159
Nazione #
US - Stati Uniti d'America 3.110
SG - Singapore 1.448
BR - Brasile 585
CN - Cina 543
IT - Italia 526
VN - Vietnam 408
SE - Svezia 371
FR - Francia 218
DE - Germania 206
IN - India 165
IE - Irlanda 123
FI - Finlandia 120
HK - Hong Kong 120
GB - Regno Unito 100
ID - Indonesia 94
JP - Giappone 85
RU - Federazione Russa 65
BD - Bangladesh 50
MX - Messico 50
CA - Canada 49
NL - Olanda 49
AR - Argentina 48
KR - Corea 33
IQ - Iraq 31
EC - Ecuador 28
TR - Turchia 28
CI - Costa d'Avorio 27
AT - Austria 24
PL - Polonia 24
ES - Italia 23
UA - Ucraina 23
ZA - Sudafrica 23
PK - Pakistan 20
VE - Venezuela 15
CO - Colombia 13
SA - Arabia Saudita 13
EG - Egitto 12
LT - Lituania 12
UZ - Uzbekistan 12
CL - Cile 11
IR - Iran 11
PY - Paraguay 11
RO - Romania 11
BE - Belgio 10
CH - Svizzera 10
JO - Giordania 10
PH - Filippine 10
KE - Kenya 9
MA - Marocco 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
PT - Portogallo 6
TW - Taiwan 5
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
AU - Australia 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
Totale 9.143
Città #
Singapore 830
Chandler 460
San Jose 369
Ashburn 351
Ho Chi Minh City 153
Beijing 147
Dallas 141
Rome 139
Dublin 118
New York 106
Hong Kong 105
Los Angeles 103
Hanoi 87
Hyderabad 87
The Dalles 87
Hefei 86
Lauterbourg 80
Jakarta 79
Council Bluffs 75
Milan 73
Tokyo 73
Helsinki 61
Boston 58
Frankfurt am Main 58
São Paulo 58
Princeton 51
Munich 47
San Mateo 41
Moscow 38
Marseille 31
Lappeenranta 30
Santa Clara 29
Seoul 29
Wilmington 29
Abidjan 27
Turku 27
Fairfield 25
Chicago 22
Da Nang 21
Kent 21
Orem 21
Atlanta 20
Rio de Janeiro 20
St Louis 20
Brooklyn 18
Falkenstein 18
Houston 18
Warsaw 18
Brasília 17
Buffalo 17
Paris 17
Mexico City 16
Montreal 16
London 15
Belo Horizonte 14
Bologna 14
Denver 14
Düsseldorf 14
Haiphong 14
Redwood City 14
Chennai 13
Hải Dương 13
Nuremberg 13
Shanghai 13
Stockholm 13
Augusta 12
Guayaquil 12
Johannesburg 12
Salt Lake City 12
Seattle 12
Baghdad 11
Bremen 11
Curitiba 11
Dhaka 11
Nanjing 11
Norwalk 11
Palermo 11
Phoenix 11
Vienna 11
Brussels 10
Manchester 10
Tashkent 10
Amman 9
Ann Arbor 9
Biên Hòa 9
Busto Arsizio 9
City of London 9
Naaldwijk 9
Poplar 9
Querétaro 9
Washington 9
Cattolica 8
Dearborn 8
Istanbul 8
Jacksonville 8
Kish 8
Loreto 8
Toronto 8
Vancouver 8
Woodbridge 8
Totale 5.194
Nome #
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 197
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 192
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 159
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 154
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 153
Radial Scar: a management dilemma 145
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 139
Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery 136
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 136
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 131
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications 126
Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study 125
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 124
Myofibroblastoma of the breast: two case reports and literature review 121
Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update 121
Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2-Sst5) 120
Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification 120
Granular Cell Tumor of the Breast: Clinical Presentation, Pathological Diagnosis and Treatment 120
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 119
OncotypeDX (R) predictive nomogram for recurrence score output: A machine learning system based on quantitative immunochemistry analysis-ADAPTED01 118
Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles 117
Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature 115
SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix 115
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 115
Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis 114
“Clock mapping” prior to excisional surgery in vulvar Paget’s disease: tailoring the surgical plan 112
Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer 109
Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes 108
Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis 108
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 107
Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis 105
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 104
An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls 104
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 104
Ovarian endometrioid carcinoma with a sex cord-like pattern: a morphological, immunohistochemical, and molecular analysis 103
Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors 103
Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease 103
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 103
Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer 102
Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE) 102
The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis 101
New pathological and clinical insights in endometrial cancer in view of the updated esgo/estro/esp guidelines 101
When a mimicker wears strange faces: Description of an osteogenic melanoma arising within an ovarian teratoma with focus on its late peritoneal relapse 101
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 101
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC) 100
The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features 99
Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma 99
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 98
Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases 98
Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors 98
The Many Faces of Endometriosis-Related Neoplasms in the Same Patient: A Brief Report 98
Peritoneal Carcinomatosis from Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma 97
Low-grade myofibroblastic sarcoma of the breast 97
Evaluation of Beta-Catenin Subcellular Localization and Water Channel Protein AQP1 Expression as Predictive Markers of Chemo-Resistance in Ovarian High-Grade Serous Carcinoma: Comparative Study between Preoperative Peritoneal Biopsies and Surgical Samples 96
Morphological and immunohistochemical evaluation in distinguishing post-radiotherapy serous-like endometrial change (PoRSEC) and serous endometrial intraepithelial carcinoma (SEIC) 95
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 95
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations 94
Breast Cancer Orbital Metastases: Clinical and Histopathological Characteristics, Imaging Features, and Disease-Related Survival in a Multicentric Retrospective Case Series 93
Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously 93
Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases 92
Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian Reporting System for Thyroid Cytology: An institutional experience. 91
A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma 91
TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review 89
Acral melanoma of the hallux 89
Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study 89
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports 89
Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis 89
Surgery after upfront chemoradiation in locally advanced squamous cell vulvar cancer: Analysis of postoperative outcomes and survival 87
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 86
Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior 86
The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease 85
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer 84
Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association 84
Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas 83
Ultra-High frequency ultrasound imaging of lymphatic channels correlates with their histological features: A step forward in lymphatic surgery 82
Ganglioglioma arising in an ovarian teratoma 82
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 82
Aberrant non-canonical WNT pathway as key-driver of high-grade serous ovarian cancer development 81
Prognostic significance of atypical mitotic figures in smooth muscle tumors of uncertain malignant potential (STUMP) of the uterus and uterine adnexa 79
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication 74
Neuroendocrine tumors of the submandibular gland: literature review and report of a case 74
Cerebellar metastasis from ovarian carcinoma harboring PIK3CA-activating mutation: A “clear” explanation for an unexpected “vertigo” 74
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives 73
The role of cytology in endometrial cancer: Diagnostic and clinical considerations from peritoneal/pelvic washings. Is it still a heated debate? 68
Breast cancer orbital metastases: Clinical, histopathological features and disease related survival in a retrospective case series 67
Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: A systematic review and meta-analysis 65
Prognostic value of the TCGA molecular classification in uterine carcinosarcoma 64
Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer 60
Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer 59
Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia 57
Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants 56
Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma 48
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer 2
Totale 9.324
Categoria #
all - tutte 39.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 21 9
2021/2022417 16 10 1 41 12 20 13 67 27 18 84 108
2022/20231.184 124 161 93 181 61 156 76 101 133 17 60 21
2023/2024723 25 203 22 32 22 125 41 29 16 45 88 75
2024/20251.806 32 29 128 54 110 75 98 67 209 269 423 312
2025/20264.922 670 197 482 694 806 220 840 286 336 326 65 0
Totale 9.324